Home » Stock Symbols » GSK.L

GlaxoSmithKline plc

GSK.L: Share Price & Live Data

-0.20 (-0.01%)
Price open 1,823.60
Previous close 1,823.00
Market cap 90.95B
Volume 7.13M
Day high 1,857.00
Day low 1,821.40
Year high 1,857.00
Year low 1,429.80

About GlaxoSmithKline plc

GlaxoSmithKline is one of the biggest pharmaceutical companies in the world. Established in 2000 following the merger of Glaxo Wellcome and SmithKline Beecham, the company has grown to become a force to reckon within the industry. However, the company’s history dates back to 1873 when Glaxo Wellcome came into being, as a company focused on the production of dried milk baby foods.

The company has since evolved and seen its core business expand to the creation, development manufacture, and marketing of medicines, vaccines, and other healthcare-related products. The company operates under four main segments of pharmaceuticals, vaccines, pharmaceutical R&D, and consumer healthcare.

Some of its flagship products include Advaim Avodart and Lovaza. It is also the owner of the first-ever malaria vaccine.

While the company boasts of primary listing in the London Stock Exchange, the stock is also listed in the New York Stock Exchange.

Latest GlaxoSmithKline plc News

U.S major pharmaceutical companies announce an increment in prices on more than 200 drugs

A healthcare research firm, 3 Axis Advisors, announced on Tuesday that major pharmaceutical companies like Sanofi SA, Pfizer, and GlaxoSmithKline have decided to hike up the U.S. list prices for as many as 200 of their manufactured drugs, with implementation plans already in action. The new prices are likely to be applicable from Wednesda...

FTSE 100 Index – A brief overview of Thursday, October 24th, 2019

In the recent news, the FTSE 100 index has been observed trading higher than expected this morning, Thursday, October 24th, 2019. While the Brexit uncertainty was expected to keep the financial markets under pressure until the decision from the European Union regarding UK’s request for an extension wasn’t announced, the market opened at 7...

FTSE 100 Index – An Insight Into The Friday Trading Session

The financial experts, analysts, investors, and traders alike have been interested in the two macro events of the U.S – China trade war and the United Kingdom’s departure from the European Union for the longest time. The global financial markets have been uncertain of their long-term intent with the developments of the two events going ba...

GSK share price: Pharmco still struggles to turn profits into cash

Hargreaves Lansdown reckons that while GlaxoSmithKline (LON:GSK) has delivered profits ahead of expectations, it is still struggling to turn them into cash, Citywire reports. The comments came after the blue-chip drugmaker posted a rise in sales and earnings earlier this week, having benefitted from strong demand for its vaccines and HIV...

GSK share price volatile as group posts rise in Q1 sales

Shares in GlaxoSmithKline (LON:GSK) have retreated in London this afternoon following an initial jump as the blue-chip drugmaker posted a rise in sales and earnings, having benefitted from strong demand for its vaccines and HIV treatments. The company, however, continues to expect a decline in full-year earnings as a generic version of it...

GSK share price outperforms as ViiV unveils upbeat trial results

Two-drug HIV regimen found to have similar efficiency to three-drug treatment


GlaxoSmithKline plc
London Stock Exchange
Drug Manufacturers—General
United Kingdom
Full time employees

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.